Disruption is a pressing problem in the pharmaceutical world; patient health depends on clinical trial organisers avoiding it ...

The FDA announced new provisions that require sponsors to submit Diversity Action Plans. But what does that mean for the ...

Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide.

Europe has been falling behind on clinical trials over the past decade as pharmaceutical companies shift their focus to the ...

AbbVie, a global, research-driven biopharmaceutical company, organized a visit to its R&D facilities—the AbbVie Cambridge ...

The FDA mandate to increase diversity in clinical trials fails to address critical issues in treatment for Black women, ...

The global pediatric clinical trial market is poised for significant growth at a CAGR of 5.9% from 2024 to 2034. The global market size is projected to reach USD 17,918.1 million in 2024. By 2034, the ...

Palleos Healthcare has a distinguished history of advancing medical innovations, leveraging its extensive experience and network to accelerate the development of new therapies. By integrating academic ...

As the pharmaceutical industry rapidly transforms, companies seeking to achieve and hold the leading positions on the market ...

Despite global clinical trials increasing by 38% over the past decade, the European Economic Area’s (EEA) global share of trials has halved over the same period. A new report by IQVIA for EFPIA and ...

Innovative products, such as those being developed by DELFI, will aid in the efficient progress of those medicines through the clinic," said Susan Macdonald, PhD, SVP Nonclinical Development & ...